Vidence, LLC is a healthcare research services company that provides our clients with real-world, tailored, comprehensive analytics on community oncology treatment. With our proprietary technology platform, SCIMON, Vidence utilizes clinical, genomic and patient-reported data to generate real-world evidence on clinical, humanistic and economic outcomes. Our goal is to expand oncology treatment options and improve the patient experience. SCIMON includes electronic health records (EHR), genomic testing data, details on medication, surgery and radiation treatment, and patient-reported outcomes among other critical data elements. With records dating back to 2012, SCIMON contains data on over 125,000 adult oncology lives, across all tumor types.